E. Zhao

发表

Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids

Jeffrey A. Cohen, Aaron E Miller, Derrick Robertson, 2022, CNS neuroscience & therapeutics.

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial

R. Furie, A. Askanase, Enxu Zhao, 2020, Lupus Science & Medicine.

Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study

R. Furie, D. Li, P. Becker, 2016, Lupus Science & Medicine.

Factors associated with abnormal spirometry among HIV-infected individuals

W. Rom, P. Diaz, A. Morris, 2015, AIDS.

A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies

M. Maris, E. Winer, P. Kaminker, 2022, Blood.

Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse.

T. Miller, M. Baker, Jeffrey Kaplan, 2021, Neurodegenerative disease management.

Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

R. Furie, A. Askanase, D. Wright, 2021, Rheumatology and Therapy.

A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse

T. Miller, M. Baker, Jeffrey Kaplan, 2020, Frontiers in Neurology.

Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

R. Furie, A. Askanase, Enxu Zhao, 2020, Rheumatology and Therapy.

Repository corticotropin injection in patients with persistently active SLE requiring corticosteroids: post hoc analysis of results from a two-part, 52-week pilot study

R. Furie, P. Becker, Enxu Zhao, 2017, Lupus Science & Medicine.

Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

G. Wan, R. Furie, A. Askanase, 2021, Rheumatology and Therapy.

757 A phase 1/1b dose escalation and cohort expansion study of MGC018 in combination with lorigerlimab in patients with advanced solid tumors (AST)

J. Powderly, E. Shenderov, P. Kaminker, 2022, Regular and Young Investigator Award Abstracts.

Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection.

S. Lipshultz, J. Reuben, Bang‐Ning Lee, 2012, Clinical immunology.

Sequential Hierarchical Regression Imputation

Trivellore E. Raghunathan, Nathaniel Schenker, Recai M. Yucel, 2018 .